Umbilical cord blood banking and transplantation: A short review

Sultan Qaboos University Medical Journal

Volumn 11, Issue 4, 2011, Pages 455-461

  Alkindi, Salam ^a   Dennison, David ^b  

^a Sultan Qaboos University College of Medicine and Health Sciences   (Oman)

^b SULTAN QABOOS UNIVERSITY HOSPITAL   (Oman)

Author keywords

Cord blood banking; Cord blood stem cell; Cord blood transplantation; National cord blood bank; Private cord blood bank; Umbilical cord blood

Indexed keywords

EID: 80055016188     PISSN: 2075051X     EISSN: 20750528     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Brunstein CG, Setubal DC, Wagner JE. Expanding the role of umbilical cord blood transplantation. Br J Haematol 2007; 137:20-35.
2. Broxymeyer HE. Cord blood hematopoietic stem cell transplantation. In: Stem Cells (internet), Cambdrige (MA): Harvard Stem Cell Institute; Update 2008-2010, 26 May 2010.
3. Bryder D, Rossi DJ, Weissman IL. Hematopoietic stem cells: Te paradigmatic tissue-specifc stem cell. Am J Pathol 2006; 169:338-46.
4. Scadden DT. Te stem-cell niche as an entity of action. Nature 2006; 1075-79.
5. Bhatia M, Bonnet D, Murdoch B, Gan OI, Dick JE. A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat Med 1998; 4:1038-45.
6. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multi-lineage potential of adult human mesenchymal stem cells. Science 1999; 284:143-7.
7. Kogler G, Calleias J, Hakenbern P, Enczmann J, Adams O, Daubener W, et al. Hematopoietic transplant potential of unrelated cord blood: Critical issues. J Hematother 1996; 5:105-16.
8. Eapen M. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukemia: A comparison study. Lancet 2007; 369:1947-54.
9. Gluckman E, Rocha V. Donor selection for unrelated cord blood transplants. Curr Opin Immunol 2006; 18:565-70.
10. Campbell TB, Hangoc G, Liu Y, Pollok K, Broxmeyer HE. Inhibition of CD 26 in human cord blood CD34+ cells enhance their engraftment of non obese-diabetic/severe combined immunodefciency mice. Stem cell Dev 2007; 16:347-54.
11. Frassoni F, Gualandi F, Podestà M, Raiola AM, Ibatici A, Piaggio G, et al. Direct intrabone transplant of umbilical cord-blood cells in acute leukaemia phase I/II study. Lancet Oncol 2008; 9:831-9.
12. Locatelli F, Rocha V, Reed W, Bernauudin F, Ertem M, Grafakos S, et al. Related umbilical cord blood transplantation in patients with thalassaemia and sickle cell disease. Blood 2003; 101:2137-43.
13. Rocha V. Lacatelli F. Searching for alternative hematopoietic stem cell donors for pediatric patients. Bone Marrow Transplantat 2008; 41:207-14.
14. Ballen K. Challenges in umbilical cord blood stem cell banking for stem cell reviewers and reports. Stem Cell Rev 2010; 6:8-14.
15. Broxmeyer HE. Umbilical cord transplantation epilogue. Semin Hematol 2010; 47:97-103.
16. Katz G, Mills A, Garcia J, Hooper K, McGuckin C, Platz A, Rebulla P, et al. Banking cord blood stem cells: attitude and knowledge of pregnant women in fve European countries. Transfusion 2011; 51:578-86.
17. Ballen K, Barker JN, Stewart SK, Greene MF, Lane TA. Collection and preservation of cord blood for personal use. Biol Blood Marrow Transplant 2008; 14:356-63.
18. Gratwohl A, Baldomero H, Frauendorfer K, Rocha V, Apperley J, Niederwieser D. Te EMBT activity survey 2006 on haematopoietic stem cells transplantation: Focus on the use of cord blood products. Bone Marrow Transplant 2008; 41:687-705.
19. Fisk NM, Atun R. Public-private partnerships in cord blood banking. BMJ 2008; 336:642-4.
20. Fisk NM, Roberts IA, Markwald R, Mironov V. Can routine commercial cord blood banking be scientifically and ethically justified? PloS Med 2005; 2:e44.
21. Edozien LC. NHS maternity units should not encourage commercial banking of umbilical cord blood. BMJ 2006; 333:801-4.
22. Kurtzberg J, Laughlin M, Graham ML, Smith C, Olson JF, Halperin EC, et al. Placental blood as a source of hematopoetic stem cells for transplantation into unrelated recipients. New Engl J Med 1996; 335:157-66.
23. Laughlin MJ, Barker J, Bambach B, Koc ON, Rizzieri DA, Wagner JE, et al. Hematopeitic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001; 344:1815-22.
24. Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Charnplin RE, et al. Outcome after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004; 351:2265-75.
25. Cohen YC, Scaradayou A, Stevens CE, Rubinstein P, Gluckman E, Rocha V, et al. Factors afecting mortality following myeloablative cord blood transplantation in adults: A pooled analysis of three international registries. Bone Marrow Transplant 2011; 46:70-6; doi:10.1038/bmt.2010.83; Epub 3 May 2010.
26. Arminan A, Gandia C, Garcia-Verduqo JM, Liedo E, Triqueros C, Ruiz-Sauri A, et al. Mesenchymal stem cells provide better results than hematopieetic processors for the treatment of myocardial infarction. J Am Coll Cardiol 2010; 55:2244-53.
27. Diaconescu R, Flowers CR, Storer B, Sorror ML, Maris MB, Maloney DG, et al. Mortality and morbidity with nonmyeloablative compared to myeloablative conditioning before haematopoietic cell transplantations from HLA matched related donors. Blood 2004; 104:1550-8.
28. Barker JN, Byan C, Scaradavou A. How I treat: Te selection and acquisition of unrelated cord blood grafts. Blood 2011; 117:2332-9.
29. Wall DA. Regulatory issues in cord blood banking and transplantation. Best Pract Res Clin Haematol 2010; 23:171-7.